GLP1R and type 2 diabetes mellitus: The binding of GLP-1R to its ligand (GLP-1) leads to the pancreatic β cells releasing glucose-dependent insulin; therefore, GLP-1R is a key target for the treatment of type 2 diabetes [135,138,139,140,141].